Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reapplix 3C Patch® System for the Treatment of Diabetic Foot Ulcers: A Medicare Claims Study

NCT03997526 is registered in ClinicalTrials.gov with Reapplix as lead sponsor.

NCT NCT03997526
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03997526 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reapplix 3C Patch® System for the Treatment of Diabetic Foot Ulcers: A Medicare Claims Study
Lead sponsor
Reapplix
Phase
Observational
Overall status
Terminated
Start date
July 15, 2020
Completion date
February 21, 2022
Enrollment
22 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic foot ulcer